- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01451008
Compression Anastomosis Using the Compression Anastomotic Ring-locking Procedure (CARP)
July 5, 2013 updated by: Region Skane
Safety Study of Compression Anastomotic Ring-locking Procedure (CARP) in Patients Undergoing Colonic Resection
The intestinal ends must be rejoined after colonic resection.
Conventional methods include sutured and stapled anastomoses, which is associated with 3-6% leakage after colonic surgery.
The leakage of an anastomosis can cause serious consequences, such as abdominal infections and/or sepsis.
Early detection of anastomotic leakage is the best way to avoid serious abdominal infections.
The methods that are used today to detect leaks are unfortunately not very accurate.
These methods include monitoring symptoms, temperature, and CRP-levels, and performing abdominal examinations and tomography scans.
Because of the difficulties in objectively assessing these parameters, the anastomotic leaks are often diagnosed late.
When reoperation is required, a permanent stoma may be made at the level of the sigmoid colon.
The CARP system has been developed to achieve a safe anastomosis.
The CARP is designed to providing an improved contact surface between the two intestinal ends and the ability to precisely investigate the anastomosis during and after surgery using the catheters of the CARP system.
Standardized use of the CARP to anastomose the large intestine may provide significant advantages in the field of colorectal surgery.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
25
Phase
- Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Skåne
-
Malmö, Skåne, Sweden, 20502
- Skåne University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 90 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age between 18 - 90 years (male or female)
- Planned resection due to benign or malign disease in the left colon
- Cognitive ability to take part in the study and understand the information he/she receives about participating in the study
Exclusion Criteria:
- Urgent medical condition requiring immediate care
- Health condition classified as ASA IV
- Albumin level less than 25 g/l
- Inflammatory bowel disease (IBD) (ulcerative colitis or Crohn´s disease)
- Disease that requires more than one anastomosis during the surgical procedure
- Treatment with cortisone and/or other immunosuppressive medications less than one month before surgery
- Contraindications to general anaesthesia
- Cognitive ability that limits the patient's ability to take part in the study and understand the information he/she received about participating in the study, or the patient does not agree to join the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Complications, including anastomotic leakage, problems with ring evacuation
Time Frame: Up to 14 days after operation
|
Up to 14 days after operation
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Time to evacuation of the CARP device
Time Frame: 1-2 week after operation
|
1-2 week after operation
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2009
Primary Completion (Actual)
September 1, 2012
Study Completion (Actual)
September 1, 2012
Study Registration Dates
First Submitted
September 26, 2011
First Submitted That Met QC Criteria
October 10, 2011
First Posted (Estimate)
October 13, 2011
Study Record Updates
Last Update Posted (Estimate)
July 8, 2013
Last Update Submitted That Met QC Criteria
July 5, 2013
Last Verified
July 1, 2013
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- CARP-002
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cancer
-
Cellworks Group Inc.RecruitingCancer | Relapsed Cancer | Refractory CancerUnited States
-
University of Michigan Rogel Cancer CenterCompletedCancer Liver | Cancer Brain | Cancer Head &Neck | Cancer PelvisUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI); Atrium Health Wake Forest BaptistRecruitingCancer | Adolescent Cancer | Young Adult CancerUnited States
-
Vanderbilt-Ingram Cancer CenterEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedAdvanced Cancer | Relapsed Cancer | Refractory CancerUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedStage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IV Gastric Cancer | Stage IVA Colorectal Cancer | Stage IVA Pancreatic Cancer | Stage IVB Colorectal Cancer | Stage IVB Pancreatic Cancer | Stage IIIA Gastric Cancer | Stage IIIB Gastric Cancer | Stage IIIC Gastric... and other conditionsUnited States
-
University of California, San FranciscoBristol-Myers Squibb; PfizerTerminatedStage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Metastatic Colorectal Adenocarcinoma | Metastatic Colon Adenocarcinoma | Metastatic Rectal Adenocarcinoma | Stage IIIA Colon Cancer | Stage IIIB Colon Cancer | Stage IIIC Colon Cancer | Stage IV Colon Cancer | Stage IV Rectal... and other conditionsUnited States
-
Yale UniversityNational Institute of Nursing Research (NINR); The Glimpse Group IncRecruitingCancer | Adolescent Cancer | Young Adult CancerUnited States
-
Palleon Pharmaceuticals, Inc.CompletedMelanoma | Cancer | Breast Cancer | Head and Neck Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | NSCLC | Non Small Cell Lung Cancer | Bladder Cancer | Colon Cancer | Urothelial Cancer | Oncology | CRC | Esophagogastric Junction Cancer | EGJUnited States
-
University of California, San DiegoWithdrawnCervical Cancer | Cervical Cancer Stage | Cervical Cancer Stage IB2 | Cervical Cancer Stage IB1 | Cervical Cancer Stage I | Cervical Cancer Stage IB | Cervical Cancer Stage II | Cervical Cancer Stage IIa | Cervical Cancer, Stage IIB | Cervical Cancer, Stage III | Cervical Cancer Stage IIIB | Cervical Cancer... and other conditionsUnited States
-
MiRXES Pte LtdRecruitingBreast Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Ovarian Cancer | Prostate Cancer | Thoracic Cancer | Liver CancerSingapore
Clinical Trials on Compression anastomotic ring-locking procedure (CARP)
-
Carponovum ABFudan UniversityTerminated
-
Carponovum ABThe First Affiliated Hospital of Xiamen UniversityCompleted